Hi, what are you looking for?

According to our latest study on “Dermal Fillers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Material, Application, and End User,” the market is projected to reach US$ 9,421.33 million by 2028 from US$ 4,391.98 million in 2021; it is estimated to grow at a CAGR of 11.5% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the dermal fillers market is primarily attributed to an increase in preference for minimally invasive procedures, growth in population belonging to age group 30–65, and rise in consumer attraction toward beauty and wellness. However, the high cost of surgeries hampers the market growth.

The Dermal Fillers is segmented based on type, end user, and geography. Geographically, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The Dermal Fillers report offers insights and in-depth analysis of the market, emphasizing parameters such as Dermal Fillers size, market trends, technological advancements in the market, and market dynamics, along with the global analysis of the competitive landscape of the leading market players that are driving the Dermal Fillers growth.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00002992/

AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, BIOXIS pharmaceuticals, HUADONG MEDICINE CO.,LTD, BIOPLUS CO., LTD., TEOXANE LABORATORIES, BIOHA LABORATORIES, and Prollenium Medical Technologies are among the leading companies operating in the dermal fillers market.

In recent years, the adoption of minimally invasive procedures has increased worldwide. A minimally invasive surgery offers patients several benefits such as smaller incisions, faster recovery times, and reduced pain and scarring. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers are injected into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. Dermal fillers are deposited slowly and steadily. They fill central folds, resulting in a natural, long-lasting outcome. Crease depth, desired effect, and patient’s financial situation needs to be considered when deciding the quantity of product to be used. According to statistics provided by the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17% in.

Age plays a significant role in defining the specific needs of medical esthetic procedures; adults more often request minimally invasive methods. Moreover, people aged 35–55 years prefer minimally invasive esthetic procedures over surgery. Plastic surgeons are becoming more willing to explore them, and minimally invasive cosmetic and esthetic procedures are now an established interdisciplinary topic. The rise of non-surgical technologies and new treatment options has made esthetics more accessible to a broader audience. Patients in their 20s and 30s are helping fuel this trend.

Based on product, the dermal fillers market is segmented into biodegradable and non-biodegradable. In 2021, the biodegradable segment is expected to hold a larger share of the market, and it is expected to register a higher CAGR in the market during the forecast period. Biodegradable fillers include collagens, hyaluronic acids (hyalurons), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue. These products are safe and are approved by the FDA. JUVÉDERM VOLUMA XC offered by Allergan plc., is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, and homogenized gel implant. In June 2020, FDA approved JUVÉDERM VOLUMA XC for enhancement of the chin area.

Based on product, the dermal fillers market is segmented into biodegradable and non-biodegradable. In 2021, the biodegradable segment is expected to hold a larger share of the market, and it is expected to register a higher CAGR in the market during the forecast period. Biodegradable fillers include collagens, hyaluronic acids (hyalurons), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue. These products are safe and are approved by the FDA. JUVÉDERM VOLUMA XC offered by Allergan plc., is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, and homogenized gel implant. In June 2020, FDA approved JUVÉDERM VOLUMA XC for enhancement of the chin area.

Based on material, the dermal fillers market is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. The hyaluronic acid segment is expected to hold the largest share of the market in 2021, and the collagen segment is anticipated to register the highest CAGR in the market during the forecast period.

The dermal fillers market, by application, is segmented into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. The facial line correction treatment segment is likely to hold the largest share of the market in 2021, whereas the facelift segment is estimated to register the highest CAGR in the market during the forecast period.

Dermal Fillers Market Segmented by Region/Country: North America, Europe, AsiaPacific, Middle East & Africa, and Central & South America

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

If you have any queries about this report or if you would like further information, please

All around the world, women in the engineering industry are inspiring more young females.

Protecting the virtual identity of users needs to be top of mind when designing the metaverse.

There are absolutely no easy fixes for this situation. Stabilizing the climate is the absolute minimum requirement.

Allen Weisselberg, the long-time chief financial officer of the Trump Organization, pleaded guilty on Thursday to tax fraud.

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.